Condensed Consolidated Statements Of Earnings (USD $) In Millions, except Per Share data, unless otherwise specified	3 Months Ended
	Mar. 30, 2013	Mar. 31, 2012
Net sales	$ 1,338	$ 1,395
Cost of sales:
Cost of sales before special charges	359	358
Special charges	18	23
Total cost of sales	377	381
Gross profit	961	1,014
Selling, general and administrative expense	468	490
Research and development expense	160	175
Special charges	25	47
Operating profit	308	302
Other expense, net	48	23
Earnings before noncontrolling interest and income taxes	260	279
Income tax expense	38	67
Net earnings before noncontrolling interest	222	212
Net loss attributable to noncontrolling interest	(1)	0
Net earnings attributable to St. Jude Medical, Inc.	$ 223	$ 212
Net earnings per share attributable to St. Jude Medical, Inc.:
Basic	$ 0.78	$ 0.67
Diluted	$ 0.78	$ 0.67
Cash dividends declared per share:	$ 0.25	$ 0.23
Weighted average shares outstanding:
Basic	285.3	315.7
Diluted	287.4	317.7